PEG as monotherapy has been proven to increase insulin sensitivity through the block of GH action at the receptor level and its consequent effect on insulin resistance and also to exert a positive impact on peripheral insulin sensitivity [19]. This evidence concerns the gene INS and Insulin resistance.